search
Back to results

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

Primary Purpose

Psychosis

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Family Focused Treatment
Enhanced Care
Sponsored by
University of California, Los Angeles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Psychosis focused on measuring Schizophrenia, psychosis

Eligibility Criteria

12 Years - 35 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age between 12 years, 0 months and 35 years, 11 months
  • Speaks and writes English
  • Availability of at least one family member for treatment
  • Meets criteria for one of three prodromal syndromes as assessed by the

Structured Interview for Prodromal Syndromes:

  1. attenuated positive symptoms that are sub-psychotic in duration and intensity and have begun or worsened in the past year;
  2. brief intermittent psychosis, defined as or syndromal psychotic symptoms that are have been present intermittently with onset in the previous 3 months; or
  3. genetic risk and deterioration, defined as a diagnosis of schizotypal personality disorder or having a first degree relative with a psychotic disorder, plus having experienced a substantial decline (30% or greater) in Global Assessment of Functioning scores in the last year.

Exclusion Criteria:

  • Diagnosis of schizophrenia or schizoaffective disorder
  • Pervasive developmental disorders
  • Current substance or alcohol dependence
  • Neurological disorders

Sites / Locations

  • UCLA School of Medicine
  • University of California, San Diego
  • Yale University
  • Emory University
  • Harvard University/Beth Israel Deconess Medical Center
  • Zucker Hillside Hospital
  • University of North Carolina
  • University of Calgary

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Family Focused Treatment

Enhanced Care

Arm Description

Family-Focused Treatment (FFT) consists of 18 sessions of psychoeducation, communication enhancement training, and problem-solving skills training in six months

Enhanced care is a 3-session family psychoeducational therapy focused on prevention of psychotic symptoms

Outcomes

Primary Outcome Measures

Change in subthreshold psychotic (positive and negative) symptoms
Participants are rated for the 3 months prior to random assignment and again at 6 and 12 months on the Structured Interview for Prodromal Symptoms (SIPS), from which attenuated psychotic (positive and negative) symptoms are rated.

Secondary Outcome Measures

Conversion to psychosis
Using the Structured Interview for Prodromal Symptoms, we assess whether the participant has converted from a subthreshold state (assessed for the 12 months prior to random assignment) to a fully syndromal psychotic state during the 12 month prospective assessment period.
Changes in psychosocial Functioning
Rating scales of global functioning (1-100 scale) and 10-point ratings of social functioning and role (e.g., academic, work) functioning

Full Information

First Posted
July 16, 2013
Last Updated
July 18, 2013
Sponsor
University of California, Los Angeles
Collaborators
National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT01907282
Brief Title
Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis
Official Title
Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis
Study Type
Interventional

2. Study Status

Record Verification Date
July 2013
Overall Recruitment Status
Completed
Study Start Date
January 2010 (undefined)
Primary Completion Date
January 2013 (Actual)
Study Completion Date
January 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles
Collaborators
National Institute of Mental Health (NIMH)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Preventing psychotic disorders such as schizophrenia and associated functional disability could relieve an enormous burden of personal and family suffering and economic losses to society. This project aims to conduct a pilot randomized trial to determine the efficacy of a family-focused treatment in comparison with treatment-as-usual in enhancing functional outcomes, stabilizing symptoms, and preventing or delaying the onset of full psychosis in transitional age youth with prodromal symptoms. The results of this study will be crucial for the development of cost-effective, evidence-based psychosocial approaches to psychosis prevention and thus will have major implications for public health.
Detailed Description
The goal of this research is to conduct a multisite randomized trial to determine the efficacy of a 6-month Family-Focused Treatment (FFT) in comparison with Enhanced Care (EC), a treatment-as-usual intervention, in reducing symptoms, enhancing functional outcomes, and preventing or delaying the onset of full psychosis in youth aged 12-35 years who meet criteria for a prodromal risk syndrome according to the Structured Interview for Prodromal Syndromes (SIPS). Our primary, secondary, and tertiary hypotheses, respectively, are that at-risk probands will respond better to FFT than EC at 6- and 12-month follow-ups, in terms of symptom trajectories (SIPS scores), social/family functioning, and first onset of full psychosis. Subjects will be drawn from the participants in a prospective, longitudinal study elucidating predictors and mechanisms of conversion to psychosis (North American Prodrome Longitudinal Study, or NAPLS), on which the sites collaborate. Subjects will be interviewed every 6 months for 1 year to assess positive and negative symptoms, academic and social functioning, family functioning, and conversion to psychosis. Recent progress in risk ascertainment methodology has enabled reliable identification of persons with prodromal or "clinical high-risk" syndromes, 35% of whom develop psychosis within 2 and ½ years. This paradigm provides an opportunity for developing and testing interventions in the prodromal phase, before the onset of full psychosis and accumulation of substantial functional disability. Psychosocial interventions appear to be well suited to address issues of motivational deficits and functional disability in the psychosis prodrome. Given our present state of knowledge regarding the mechanisms of psychosis onset, and given that initial studies of antipsychotic drugs in prodromal patients have produced discouraging results in terms of prevention, a short term reduction in symptom severity and functional disability may represent a more achievable target than a reduction in psychosis incidence. We have developed and piloted a version of FFT for clinical high risk youth (FFT-CHR) consisting of psychoeducation, communication training, and problem-solving skills training. In randomized trials, adults and adolescents with bipolar disorder and children at-risk for bipolar disorder undergoing FFT improved symptomatically and functionally compared to patients in brief psychoeducational control conditions. Further, an open trial of family psychoeducation for youth at risk for psychosis demonstrated symptomatic and functional improvements relative to baseline scores. However, no randomized controlled study has examined the efficacy of FFT for reducing symptoms or functional disability in youth at risk for psychosis. In view of the improvements in quality of life and the reductions in costs of care that have occurred with preventive approaches to cardiovascular disease, diabetes, and certain forms of cancer, the field of psychiatry is in need of a major commitment to an early detection/prevention framework for its most debilitating syndromes - the psychotic disorders. The prodromal risk syndrome criteria have resulted in clinical algorithms that are highly effective in predicting onset of full psychosis. However, such knowledge will be of limited utility if we lack the means of intervening in the pre-onset phase in a way that either reduces the likelihood of progression to full psychosis, the accumulation of functional disability, or both. There are currently no cost-effective, evidence-based psychosocial approaches to psychosis prevention. Preventing the neurotoxic effects of early episodes, before these illnesses become chronic, and minimizing the psychosocial sequelae of early episodes, may do much to prevent the long-term disability caused by psychosis and thereby have a major impact on public health. Our study will take the critical next step by performing an initial efficacy test of a highly promising family-focused intervention designed to stabilize symptoms and improve social and role functioning in at risk youth.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychosis
Keywords
Schizophrenia, psychosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
129 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Family Focused Treatment
Arm Type
Experimental
Arm Description
Family-Focused Treatment (FFT) consists of 18 sessions of psychoeducation, communication enhancement training, and problem-solving skills training in six months
Arm Title
Enhanced Care
Arm Type
Active Comparator
Arm Description
Enhanced care is a 3-session family psychoeducational therapy focused on prevention of psychotic symptoms
Intervention Type
Behavioral
Intervention Name(s)
Family Focused Treatment
Other Intervention Name(s)
Family Therapy, Family Psychoeducation, Behavioral Family Therapy
Intervention Description
Treatment for family that focuses on skills for coping with subthreshold positive and negative symptoms and improving family communication and problem-solving
Intervention Type
Behavioral
Intervention Name(s)
Enhanced Care
Other Intervention Name(s)
Brief psychoeducation
Intervention Description
This 3-session psychoeducational treatment assists individuals and families in coping with early warning signs of psychotic episodes.
Primary Outcome Measure Information:
Title
Change in subthreshold psychotic (positive and negative) symptoms
Description
Participants are rated for the 3 months prior to random assignment and again at 6 and 12 months on the Structured Interview for Prodromal Symptoms (SIPS), from which attenuated psychotic (positive and negative) symptoms are rated.
Time Frame
Change from pretreatment (assessed for the 3 months prior to randomization) to 12 month reassessment
Secondary Outcome Measure Information:
Title
Conversion to psychosis
Description
Using the Structured Interview for Prodromal Symptoms, we assess whether the participant has converted from a subthreshold state (assessed for the 12 months prior to random assignment) to a fully syndromal psychotic state during the 12 month prospective assessment period.
Time Frame
Onset of a fully syndromal period of psychosis during the 12 month study
Title
Changes in psychosocial Functioning
Description
Rating scales of global functioning (1-100 scale) and 10-point ratings of social functioning and role (e.g., academic, work) functioning
Time Frame
Change from pretreatment (1 month prior to randomization) to 12 months
Other Pre-specified Outcome Measures:
Title
Changes in family interactional behavior
Description
Based on 10-minute family interactions, we assess communication and problem-solving behavior in the family from before to after family-focused treatment or enhanced care treatment.
Time Frame
Change from baseline (beginning of psychosocial treatment) to 6 month reassessment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age between 12 years, 0 months and 35 years, 11 months Speaks and writes English Availability of at least one family member for treatment Meets criteria for one of three prodromal syndromes as assessed by the Structured Interview for Prodromal Syndromes: attenuated positive symptoms that are sub-psychotic in duration and intensity and have begun or worsened in the past year; brief intermittent psychosis, defined as or syndromal psychotic symptoms that are have been present intermittently with onset in the previous 3 months; or genetic risk and deterioration, defined as a diagnosis of schizotypal personality disorder or having a first degree relative with a psychotic disorder, plus having experienced a substantial decline (30% or greater) in Global Assessment of Functioning scores in the last year. Exclusion Criteria: Diagnosis of schizophrenia or schizoaffective disorder Pervasive developmental disorders Current substance or alcohol dependence Neurological disorders
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David J Miklowitz, PhD
Organizational Affiliation
UCLA Semel Institute
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Tyrone Cannon, Ph.D.
Organizational Affiliation
Yale University
Official's Role
Study Director
Facility Information:
Facility Name
UCLA School of Medicine
City
Los Angeles
State/Province
California
ZIP/Postal Code
90025
Country
United States
Facility Name
University of California, San Diego
City
San Diego
State/Province
California
ZIP/Postal Code
92093
Country
United States
Facility Name
Yale University
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06519
Country
United States
Facility Name
Emory University
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30322
Country
United States
Facility Name
Harvard University/Beth Israel Deconess Medical Center
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02215
Country
United States
Facility Name
Zucker Hillside Hospital
City
New York
State/Province
New York
ZIP/Postal Code
11004
Country
United States
Facility Name
University of North Carolina
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States
Facility Name
University of Calgary
City
Calgary
State/Province
Alberta
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
22182667
Citation
Schlosser DA, Miklowitz DJ, O'Brien MP, De Silva SD, Zinberg JL, Cannon TD. A randomized trial of family focused treatment for adolescents and young adults at risk for psychosis: study rationale, design and methods. Early Interv Psychiatry. 2012 Aug;6(3):283-91. doi: 10.1111/j.1751-7893.2011.00317.x. Epub 2011 Dec 20.
Results Reference
background
PubMed Identifier
25062592
Citation
Miklowitz DJ, O'Brien MP, Schlosser DA, Addington J, Candan KA, Marshall C, Domingues I, Walsh BC, Zinberg JL, De Silva SD, Friedman-Yakoobian M, Cannon TD. Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial. J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):848-58. doi: 10.1016/j.jaac.2014.04.020. Epub 2014 Jun 2.
Results Reference
derived

Learn more about this trial

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

We'll reach out to this number within 24 hrs